Tallinn 2022

“Achieving and Maintaining Remission”

Tallinn, Estonia, 25-27 May 2022

Wednesday, May 25

Relapse After Successful ECT: State-of-the-art” – Pascal Sienaert (BEL)

Relapse Prevention with Maintenance ECT: State-of-the-art” – Charles Kellner (USA)

Implementation of Maintenance ECT – Practical Issues to Be Considered” – Kara Hannigan (UK)

Cognitive Effects and ECT-related Anxiety During mECT” – Jasmien Obbels (BEL)

Termination of Acute Treatment of ECT – When and What Next” – Håkan Odeberg (SWE)


Thursday, May 26

Quality and Standards in ECT: a Role for Nursing Leadership?” – Kara Hannigan (UK)

Does ECT Cause Cumulative Cognitive Deficits?” – George Kirov (UK)

The Role of Maintenance ECT in Schizophrenia” – Gabor Gazdag (HUN)

Lithium for Post-ECT Depressive Relapse Prevention: Where Should We Go?” – Simon Lambrichts (BEL)

Lessons from COVID-19: ECT is not an Elective Treatment” – Alexander Sartorius (GER)

Dosing Methods in Electroconvulsive Therapy: Should the Scandinavian Time-titration Method be Resumed?” – Per Bergsholm (NOR)


Friday, May 27

rTMS for Depression” – Marcus Persson (SWE)

Maintenance rTMS Treatment and rTMS for Comorbid Somatic and Psychiatric Disorders” – Tero Taiminen (FIN)

Overview of fMRI targeted rTMS” – Tuukka Raij (FIN)

Deep rTMS for the Treatment of Alcohol Use Disorders?” – Irene Perini (SWE)

Deep Brain Stimulation in the Treatment of Major Depressive Disorder and OCD” – Matilda Naesström (SWE)